The use of different vaccination schedules for sows to protect piglets against Aujeszky's disease

J Vet Med B Infect Dis Vet Public Health. 2004 Feb;51(1):8-11. doi: 10.1046/j.1439-0450.2003.00721.x.

Abstract

Several Aujeszky's disease virus (ADV) vaccination protocols of sows were evaluated with regard to the passive protection conferred on piglets in a recently built commercial farm. Three different groups of sows were vaccinated using a Bartha K-61 strain. One group received an inactivated vaccine during pregnancy and the other two groups received attenuated vaccines, either during pregnancy (day 65) or on the seventh day of lactation. At farrowing, sows vaccinated during lactation had lower seroneutralization titres than those vaccinated during pregnancy either with inactivated or attenuated vaccines. Accordingly, their piglets were the ones with lower levels of maternally transferred neutralizing antibodies. At 4 weeks of age, five piglets born of each group of sows were challenged intranasally with a neurotropic strain of ADV. Piglets born of sows vaccinated during pregnancy with inactivated and attenuated vaccines gained 1.50 kg bodyweight and 2.50 kg bodyweight during 7 days, respectively, and did not show clinical signs, while piglets from sows vaccinated during the previous lactation lost 0.60 kg and presented moderate to severe clinical signs of ADV. Vaccination of sows during pregnancy provided more protection against ADV for piglets than sow vaccination before mating. Piglets born from sows vaccinated with attenuated or inactivated vaccines did not present remarkable differences on protection.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Animals
  • Animals, Newborn
  • Antibodies, Viral / analysis
  • Enzyme-Linked Immunosorbent Assay / veterinary
  • Female
  • Herpesvirus 1, Suid / immunology*
  • Male
  • Pseudorabies / prevention & control*
  • Swine
  • Swine Diseases / prevention & control*
  • Treatment Outcome
  • Vaccination / veterinary*
  • Viral Vaccines / administration & dosage*

Substances

  • Antibodies, Viral
  • Viral Vaccines